Literature DB >> 18972380

Animal models of obsessive-compulsive disorder.

Jeffrey M Witkin1.   

Abstract

Obsessive-compulsive disorder (OCD) occurs with high prevalence, and the drugs used to treat OCD are limited in efficacy and have side-effect issues. The discovery of improved medicines for OCD has been hampered in part by the lack of predictive in vivo models. This unit provides a brief overview of two methods that might have such predictive utility. Marble burying and nestlet shredding are two behaviors that occur spontaneously with high frequency and repetitiveness in mice. These acute in vivo assays are relatively easy to conduct. Selective serotonin uptake inhibitors decrease these behaviors without producing motor side effects, as assessed by the behavior of walking on a rotating rod. In contrast, some other drugs (e.g., benzodiazepine anxiolytics) only affect marble burying and nestlet shredding at motor-impairing doses. The present methods might therefore provide one piece of in vivo information for the discovery of novel chemical treatment solutions for the symptoms of OCD. Copyright 2008 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18972380     DOI: 10.1002/0471142301.ns0930s45

Source DB:  PubMed          Journal:  Curr Protoc Neurosci        ISSN: 1934-8576


  13 in total

1.  Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Catherine E Sykes; Mrudang M Shah; Dina M Francescutti; David R Rosenberg; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2012-04-13       Impact factor: 5.372

2.  Hypothalamic Agrp neurons drive stereotypic behaviors beyond feeding.

Authors:  Marcelo O Dietrich; Marcelo R Zimmer; Jeremy Bober; Tamas L Horvath
Journal:  Cell       Date:  2015-03-05       Impact factor: 41.582

Review 3.  The age of anxiety: role of animal models of anxiolytic action in drug discovery.

Authors:  John F Cryan; Fabian F Sweeney
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

4.  Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3.

Authors:  Timothy M DeLorey; Peyman Sahbaie; Ezzat Hashemi; Wen-Wu Li; Ahmad Salehi; David J Clark
Journal:  Behav Brain Res       Date:  2010-08-10       Impact factor: 3.332

5.  Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex.

Authors:  Robert P Carson; Cary Fu; Peggy Winzenburger; Kevin C Ess
Journal:  Hum Mol Genet       Date:  2012-10-09       Impact factor: 6.150

6.  Stimulation of 5-HT2C receptors improves cognitive deficits induced by human tryptophan hydroxylase 2 loss of function mutation.

Authors:  Thomas Del'Guidice; Francis Lemay; Morgane Lemasson; Jean Levasseur-Moreau; Stella Manta; Adeline Etievant; Guy Escoffier; François Y Doré; François S Roman; Jean-Martin Beaulieu
Journal:  Neuropsychopharmacology       Date:  2013-11-07       Impact factor: 7.853

7.  Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Dina M Francescutti; Donald M Kuhn
Journal:  J Vis Exp       Date:  2013-12-24       Impact factor: 1.355

8.  Anxiolytic effects and neuroanatomical targets of estrogen receptor-β (ERβ) activation by a selective ERβ agonist in female mice.

Authors:  Mario G Oyola; Wendy Portillo; Andrea Reyna; Chad D Foradori; Andrea Kudwa; Laura Hinds; Robert J Handa; Shaila K Mani
Journal:  Endocrinology       Date:  2011-12-20       Impact factor: 4.736

9.  Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism.

Authors:  Michael J Kane; Mariana Angoa-Peréz; Denise I Briggs; Catherine E Sykes; Dina M Francescutti; David R Rosenberg; Donald M Kuhn
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

10.  Low-Expressing Synucleinopathy Mouse Models Based on Oligomer-Forming Mutations and C-Terminal Truncation of α-Synuclein.

Authors:  Ana Martinez Hernandez; Ivan Silbern; Insa Geffers; Lars Tatenhorst; Stefan Becker; Henning Urlaub; Markus Zweckstetter; Christian Griesinger; Gregor Eichele
Journal:  Front Neurosci       Date:  2021-06-17       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.